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Abstract36
37
The response of bacterial biofilms to treatment with antimicrobial agents is often characterized38
by the emergence of recalcitrant cellular microcolonies. We present an individual-based model39
to investigate the biophysical mechanisms of the selective resistance that arises within the40
biofilm and leads to a spatially heterogeneous response upon treatment with antibiotics. The41
response occurs in three distinct phases. In the first phase, the subpopulation of metabolically42
active cells diminishes due to antibiotic-induced cell death.  Subsequently, in the second phase,43
increased nutrient availability allows dormant cells in the lower layers of the biofilm to transform44
into metabolically active cells. In the third phase, survival of the biofilm is governed by the45
interplay between two contrasting factors: (i) rate of antibiotic-induced cell death, and (ii) rate of46
transformation of dormant cells into active ones. Metabolically active cells at the distal edge of47
the biofilm sacrifice themselves to protect the dormant cells in the interior by (i) reducing local48
antibiotic concentrations, and (ii) increasing nutrient availability.  In the presence of quorum49
sensing, biofilms exhibit increased tolerance compared to the quorum sensing-negative strains.50
EPS forms a protective layer at the top of the biofilm, thereby limiting antibiotic penetration.51
The surviving cells, in turn, produce EPS resulting in a feedback-like mechanism of resistance.52
Whereas resistance in QS- biofilms occurs because of transformation of dormant cells into53
metabolically active cells, this transformation is less pronounced in QS+ biofilms, and resistance54
is a consequence of the sequestration of the antibiotic by EPS.55
56
57
Introduction58
Biofilms are surface-associated communities of microorganisms embedded in an extracellular59
matrix composed primarily of self-produced polysaccharides [1, 2]. Biofilms shelter bacteria60
from environmental stresses and from the host immune response, thereby increasing resistance to61
antibiotics and phagocytosis, as well as to other components of the innate and adaptive immune62
systems [3, 4]. Several mechanisms -- acting synergistically -- contribute to the reduced63
antimicrobial and biocide susceptibility that is characteristic of biofilm communities. Expression64
of specific genes may allow biofilm bacteria to actively adapt to, and survive, antimicrobial65
exposure [5-9]. For instance, the ndvB locus has been identified as a Pseudomonas aeruginosa66
(P. aeruginosa) biofilm-specific antibiotic resistant gene; ΔndvB biofilms were 16-fold more67
susceptible to tobramycin and 8-fold more susceptible to both gentamicin and ciprofloxacin than68
wild-type biofilms [10]. In response to antibiotic treatment, overexpression of toxins that inhibit69
essential functions such as translation may contribute to the transformation of biofilm bacteria to70
an antibiotic tolerant phenotype [11]. These genetic mechanisms attribute resistance of the71
biofilm to antibiotic tolerance at the single-cell level [12, 13].72
Antibiotic resistance may also emerge as a consequence of physiological characteristics inherent73
to the biofilm mode of growth [1, 14]. Biofilms are characterized, among other things, by the74
presence of nutrient and antibiotic gradients, diffusion and penetration limitations, and a matrix75
of extracellular polymeric substances (EPS) [15-17]. Bacteria growing in biofilms are76
physiologically heterogeneous, due in part to their adaptation to local environmental conditions.77
They occupy a spectrum of growth states from rapidly growing and active to slow-growing and78
dormant. Consequently, distinct microcolonies with clusters of bacterial cells may develop79
within the biofilm where cellular physiology is different from surroundings in terms of metabolic80
activity, secretion of EPS, and concentrations of nutrients and antimicrobial agents [17-20]. This81
intrinsic physiological heterogeneity of biofilms may play a role in the adaptive stress response,82
and contribute to the protection of cells [21]. Experimental evidence suggests that it is only83
certain subpopulations within biofilms that show greatly increased phenotypic resistance to84
treatment, whereas the remaining cells exhibit sensitivity [22-24]. A particular antimicrobial85
agent may effectively target certain populations of cells, but leave the remaining cells viable,86
allowing them to repopulate the biofilms when the treatment is stopped. For instance, cells deep87
within P. aeruginosa biofilms are reported to be in a metabolically inactive, antibiotic-tolerant88
state, whereas cells at the periphery are faster growing, and susceptible to antimicrobial agents89
such as ciprofloxacin, tetracycline, and tobramycin [25, 26]. The biophysical mechanisms90
underlying this spatially non-uniform response of biofilms to antimicrobial treatment remain91
incompletely understood.92
The lowest concentration of the antimicrobial agent required to eradicate the biofilm is termed93
the minimum biofilm eradication concentration (MBEC) [27].  Subjecting the biofilm to sub-94
lethal concentrations of the antibiotic (sub-MBEC) enhances biofilm formation in vitro [28-30].95
For instance, subjecting P. aeruginosa biofilms to sub-MBEC treatment induces genetic triggers96
that result in the enhanced formation of colonic acid [31].  This, in turn, causes an increase in the97
synthesis of EPS which contributes to the protection of the bacterial population. Antibiotic-98
induced biofilm formation has clinical relevance because bacteria are exposed to low99
concentrations of antibiotics at the beginning and the end of treatment, or continuously during100
low-dose therapy [30]. Investigating the reasons for survival of biofilms in response to sub-101
MBEC treatment of antibiotics may help delineate biophysical mechanisms of antibiotic102
resistance.103
Quorum sensing (QS) is a process by which bacteria coordinate their behavior in a cell-density104
dependent manner by producing and detecting signaling molecules called autoinducers [32-34].105
QS has been shown to control the amount of EPS synthesis in P. aeruginosa biofilms [35-39].106
Furthermore, experimental investigations support the role of QS-regulated EPS in the resistance107
of P. aeruginosa biofilms to antibiotic treatment [40]. The EPS matrix protects the biofilm by108
impeding penetration of tobramycin via ionic interactions at the periphery [39, 41]. In addition,109
antibiotic susceptibility of Staphylococcus aureus biofilms towards vancomycin increases in the110
presence of QS-inhibitors by deactivating EPS biosynthesis [42]. Nutrient concentration111
gradients in QS+ biofilms may induce spatio-temporal heterogeneity in autoinducer secretion,112
which may, in turn, result in microscale variation in EPS production.  How the spatial113
heterogeneity of EPS influences the heterogeneous response of biofilms to antibiotics is currently114
not known.115
We have previously formulated and analyzed a three-dimensional, individual-based116
computational model to simulate biofilm growth dynamics, and to quantify spatial heterogeneity117
in the bacterial population as a function of nutrient availability and quorum sensing [43].  The118
model treats bacterial cells as individual entities with their own states, thereby allowing for119
variability between individual behaviors with respect to their growth rates, antibiotic and nutrient120
uptake rates, autoinducer production, up-regulation and down-regulation states, and EPS121
secretion.  The individual-based, discrete nature of the model, combined with physical dynamics122
causes chemical and structural heterogeneities within the biofilm to emerge as a consequence of123
the actions and interactions of the cells with each other, and with the surrounding environment,124
rather than being a model input.  In this work, we investigate the response of QS- and QS+125
biofilms to treatment with antibiotics, and the influence of heterogeneity on this response. The126
goal was to answer the following questions: (1) Do local physiological and chemical127
heterogeneities in the biofilm influence the spatially heterogeneous antibiotic resistance in the128
absence of genetic triggers? (2) What roles do biophysical and cellular processes play in129
enhanced biofilm formation in response to treatment with sub-lethal doses of antibiotics? (3)130
What role does EPS play in the heterogeneous response of the biofilm to antibiotic treatment?131
Our results indicate that during the initial stages of treatment, the proportion of the fast-growing,132
metabolically active subpopulation decreases due to exposure to the antibiotic.  This results in an133
increase in the nutrient availability to the dormant cells in the inner regions of the biofilm.  We134
propose that this triggers a transformation from the dormant state to the metabolically active135
state, and that this transformation is a key mechanism of resistance. When subjected to sub-136
MBEC treatment, antibiotic-induced cell death at the biofilm surface leads to increased nutrient137
availability in the inner regions, resulting in enhanced growth compared to the untreated biofilm.138
Due to the protective influence of EPS, QS+ biofilms required a higher concentration of the139
antibiotic to eradicate compared to the QS- biofilms.140
141
142
Methods143
144
Model description and simulation domain145
We used a 3D individual-based model to simulate the growth dynamics of a bacterial biofilm in146
response to treatment with antibiotics. Biofilm growth is simulated within a rectangular box147
whose bottom surface (120 µm x 120 µm) represents the inert substratum. A reservoir of148
nutrient is placed at the top at a constant distance from the substratum, and is continuously149
replenished so that a constant concentration is maintained in the bulk phase.  The interface150
between the reservoir and the biofilm domain is termed the diffusion boundary layer (DBL). The151
space between the DBL and the substratum is discretized into cubical elements of volume 27152
µm3 each. During the simulation, each element may be occupied by one or more of the153
following entities: (i) bacterial cell, (ii) EPS, (iii) nutrient, (iv) autoinducer, and (v) antibiotic.154
Periodic boundary conditions are applied in the horizontal directions, thereby eliminating edge155
effects, and ensuring continuity of biomass [44, 45]. Each bacterium is modeled as a distinct156
entity with its own set of parameter values and behaviors.  To simulate behavioral variability,157
parameter values for individual bacterial cells are obtained by random draws from a uniform158
distribution around the values listed in Table 1. The simulation represents a time march in which159
the occupancy state of each element is updated at every time step.  At time t = 0, six cells, termed160
colonizers, are placed into random elements atop the substratum.  Simultaneously, nutrient161
diffuses across the DBL.  Cells consume nutrient, and subsequently grow and divide, resulting in162
the formation of a contiguous multicellular population.  At the end of each time step, the nutrient163
reservoir is shifted vertically upwards such that a pre-determined distance from the topmost cell164
in the biofilm is always maintained.165
166
Assumptions167
The following are the key assumptions made:168
(1) The biofilm does not pose an obstacle to flow, and is subjected to a constant linear velocity169
gradient of 10 s-1 with zero velocity at the substratum, and maximum velocity at the highest170
point.  It has been shown that giving up the conservation principles for fluid flow in the171
biofilm domain leads to increased deviations with respect to concentration fields and fluxes172
[46].  The magnitude of deviation is in some cases small (< 2%, at slow bulk flow velocities173
of ~0.0001 ms-1), and considerable in other (> 20%, at fast bulk flow velocities of 0.01 ms-1).174
The results presented in this work correspond to the low bulk flow regime (maximum175
velocity of ~0.0006 ms-1).  Consequently, deviations in concentration fields and fluxes have176
been neglected.  Such low fluid shear rates (10-50 s-1), experienced within the intestine, and177
veins, have been shown to be effective in simulating S. aureus biofilm colonization and178
development [47, 48].179
(2) The DBL remains parallel to the substratum throughout the simulation.  It is worth noting180
that at high fluid velocities, the diffusion boundary could follow the surface of the biofilm,181
and may not be necessarily stratified as is assumed here [49].182
(3) The DBL has a constant thickness of 18 µm.  For the low-flow regime considered in this183
work, the nutrient concentration at a vertical distance of 18 µm from the highest cell in the184
biofilm was greater than 95% of the bulk nutrient concentration, even at time points185
corresponding to the highest cell numbers.186
(4) EPS is capable of coexisting with a bacterial cell within a cubical element. This is consistent187
with previous experimental work showing the accumulation of extracellular polysaccharides188
such as β-glucan found intercalating between micro colonies of Streptococcus mutans [50].189
Consequently, we assume that new bacterial cells embed themselves into existing EPS,190
instead of pushing it aside.191
(5) Negative parameter values of individual bacterial cells, or those outside ±10% of the mean192
were discarded; these precautions are necessary with distributions ranging from −∞ to +∞.193
194
A full mathematical description of the various components and processes incorporated in the195
model has been presented elsewhere [43]. Here, we briefly present the governing equations,196
behaviors of the particulate and soluble entities, and the numerical scheme used.197
198
Nutrient reaction and transport199
The rate of consumption of the nutrient by bacteria is a function of the concentrations of the200
biomass ( ( ̅, )) and the nutrient ( ̅, ) at the spatial coordinates ̅ and time , and is given201
by202
203 ( , ) = + ( , )( , )204
205
where is the maximum specific growth rate, and are the yield and maintenance206
coefficients, respectively, and is the half saturation concentration of the nutrient ( ). The207
nutrient concentration field is governed by the reaction-diffusion-convection equation (Eq. 2)208
209 ( , ) = − ( , ), ( , ) + ∑ ( , ) − ∇ ∙ ( )210
211
Here, is the nutrient diffusivity, and is the local fluid velocity. ( , ) is set to ,212
at the top surface, and to 0 at the substratum. Periodic boundary conditions are applied at the213
lateral boundaries.214
215
Biomass growth216
Consumption of nutrient leads to cell growth, and endogenous metabolism. Endogenous217
metabolism is assumed to be proportional to the biomass concentration. The leftover nutrient is218
utilized for cell growth at an efficiency . The net accumulation of biomass is, given by:219
220 ( , ) = ( , ), ( , ) − ( , )221
222
(2)
(3)
(1)
223
Cell division224
When the biomass of a cell increases to twice its native value it divides into two daughter cells.225
One daughter cell continues to occupy the same element as the mother cell, while the other is226
pushed into a cell-free element in the immediate, Moore neighborhood. For each cell, the Moore227
neighborhood, comprises of 26 cubical elements surrounding the central element.  If multiple228
cell-free elements are available for occupation, one is chosen at random.  On the other hand, if all229
elements in the Moore neighborhood are occupied by bacteria, an unoccupied element is230
identified at the nearest Chebyshev distance from the location of the mother cell.  The occupancy231
statuses of elements are checked at successively larger Chebyshev distances (starting with a232
Chebyshev distance of 2, and moving outward, layer by layer), until an empty element is found.233
Each of the cells that lies between the mother cell and the closest cell-free element is then shifted234
by one grid element – away from the mother cell, and towards the empty element – creating a235
cell-free element in the Moore neighborhood of the mother cell.  This newly created cell-free236
element is then occupied by the daughter cell, thereby ensuring that the daughter cell is always237
placed immediately next to the dividing bacterium [43].238
239
Cell death240
The nutrient uptake rate ( ) is defined as the ratio of the nutrient uptake rate ( ) to endogeneous241
metabolism ( ). There are three mechanisms by which a bacterium can die: (i) limited242
nutrient uptake rate ( ), (ii) stay in the stationary phase for a predetermined number of hours243 ( ), and (iii) exposure to antibiotic.  If > 1, the bacterium exhibits net growth.  On the other244
hand, for < 1, the bacterium shows negative net growth, and is said to have entered the245
stationary phase.  Bacteria die if R falls below a certain threshold ( ). This is an attempt to246
account for bacterial death under nutrient starvation conditions. Bacteria also die if they have247
been in this growth-arrested phase for a pre-specified number of hours ( ).  This is recorded248
with an individual based counter. If R is below 1 during one hour, the counter increases by one.249
However, a bacterium also has the possibility to recover if R increases above 1 before it dies.250
Consequently, if R is above 1 during one hour, the counter decreases by one.  The counter can251
never be less than zero. Moreover, if the biofilm is subjected to antibiotic treatment, then cells252
die based on probability of killing by antibiotic which is a function of the rate of consumption of253
antibiotic (Eq. 13).254
255
Cell detachment256
We implement a simplified geometrical model of cell detachment governed by (i) localized cell257
death, and (ii) EPS formed as a consequence of quorum sensing.  Cell detachment is determined258
by evaluating the connectivity of cells to the substratum.  Within the biofilm, bacteria connect to259
the substratum either directly, or indirectly through a group of live bacteria in which at least one260
bacterium is directly bound to the substratum [51].  In addition to live bacteria, in QS+ biofilms,261
cells can also continue to remain connected to the substratum via EPS.  At the end of each time262
step, detachment events are recorded, and detached cells are removed from the domain.263
264
265
Quorum Sensing266
Every bacterium that engages in quorum sensing is allowed to switch randomly between the up-267
regulated, and the down-regulated state, at rates, dependent on the local autoinducer268
concentration ( ̅, ) in the grid element. At time t = 0, all the bacteria are in the down-269
regulated state. The transition rate from the down-regulated to up-regulated state is given by270 = ( ̅, )1 + ( ̅, )
271
While, the transition rate between the up-regulated to down-regulated states is given by [52]272 = 11 + ( ̅, )
273
where and are the spontaneous up- and down-regulation rates, and is the transition274
constant.275
276
Within a time interval of Δ , the probabilities of switching from one state to another are then277
given by278
279 = ( )∆280 = ( )∆
where is the probability of up-regulation, and is the probability of down-regulation.281
282
For each bacterium, at every time step, the simulation generates a random number (nR) from a283
uniform distribution on the interval [0, 1].  If > , then the bacterium switches from the284
down-regulated state to an up-regulated state. On the other hand, if > , then the bacterium285
switches from the up-regulated to the down-regulated state.286
287
Autoinducer Production and Transport288
Up-regulated and down-regulated cells secrete autoinducer molecules at constant rates of ,289
and , , respectively.290 = ,,
where , > , (Table I). The secreted autoinducer is treated as a dissolved entity that is291
transported via diffusion and convection.  The time evolution of autoinducer concentration292
within the biofilm is given by293 ( ̅, ) = ( ̅, ) + Δ − ∇ ∙ ( )
where is the autoinducer diffusivity, and Δ is the element volume.  Eq. 8 is subject to the294
Dirichlet boundary condition at the DBL ( , = 0), and the no-flux condition at the295
substratum. Upregulated cells secrete autoinducer molecules and EPS at an enhanced rate,296
compared to their downregulated counterparts [52, 53]. In a feedback-like mechanism, enhanced297
(5)
(7)
(8)
(6)
(4)
production of autoinducer by upregulated cells results in the upregulation of an increasing298
number of cells in the neighborhood.299
300
EPS Production301
EPS is treated as a discrete entity and is tracked individually in a manner similar to that of302
bacterial cells. Bacterial growth and EPS production are assumed to occur concurrently from303
nutrient that is leftover after maintenance has been accounted for.  EPS is produced only by304
upregulated cells, at a rate given by305
306 ( ̅, ) = ( ̅, ), ( ̅, ) − ( ̅, )
307
where, is the yield coefficient for EPS, i.e. the efficiency with which unutilized nutrient is308
converted to EPS. EPS do not grow, die or consume nutrient, but they occupy space and309
undergo division. EPS division is handled similar to cell division described above, wherein310
daughter “EPS cells” are placed into the nearest element that does not contain EPS. The311
consumption of antibiotic by EPS is governed by Monod-like kinetics (Eq. 11). This is an312
attempt to account for the reaction-diffusion barrier to penetration by the antibiotic that EPS313
provides.314
315
Diffusion and reaction of antibiotics316
In select runs, the biofilm is subjected to a continuous antibiotic treatment for a duration of 24 h.317
The antibiotic concentration in the bulk fluid is held constant throughout the treatment period.318
As the antibiotic diffuses through the DBL, live bacterial cells and EPS consume the antibiotic in319
a Monod-like reaction [54]. The consumption of antibiotic by non-quorum sensing bacteria is320
assumed to be a function of the local antibiotic concentration and biomass concentrations, is321
given by Eq. (10)322
323 ( ̅, ), ( ̅, ) = ( ̅, )( ̅, ) ( ̅, )324
325
where is the maximum specific reaction rate of antibiotic with respect to biomass, is326
the Monod half-saturation coefficient of antibiotic, and ( ̅, ) = ( , , , ) represents local327
antibiotic concentration in each grid element, at time point t. In QS+ biofilms, the consumption328
of antibiotic by bacteria and EPS, is given by Eq. (11).329
330 ( ̅, ), ( ̅, ) = ( ̅, )( ̅, ) [ ( ̅, ) + ( ̅, )]331
332
where represents the maximum specific reaction rate of antibiotic by EPS, and333
represents the EPS biomass. The dynamics of the antibiotic concentration field ( ̅, ) is334
given by the following reaction-diffusion equation:335
336
(11)
(9)
(10)
( , ) = − ( , ), ( , ) + ∑ ( , )− ∇ ∙ ( )337
338
where is the antibiotic diffusivity, and is the local fluid velocity.339
340
The probability of cell death due to antibiotic consumption is given by:341 = ( ̅, ) −−
342
and are the rates of consumption of the antibiotic at minimum and maximum343
inhibitory concentrations of one bacterium, respectively. At each time step during treatment, a344
random number (nR) is generated for each cell. If > , then the bacterium dies, and is345
removed from the simulation domain.346
347
Bacterial heterogeneity based on growth rates348
Cells within the biofilm are classified into three groups based on their growth rates: cells349
exhibiting (i) high (HGR), (ii) intermediate, and (iii) low growth rates (LGR). The growth rate350
of each cell is evaluated as the change in biomass over a period of 4 h. Growth rates vary from351
~10 to ~10,000 gm-3h-1. After 64 h of growth (in the absence of antibiotic treatment), cells are352
sorted from highest to the lowest growth rates.  The top 10% of the cell population is classified353
as HGR, and the bottom 10% as LGR. This percentage of HGR is in agreement with354
experimental observations that suggest that the proportion of active bacteria in biofilms is range355
from ~5-35% [55, 56]. Using this methodology, the threshold growth rate above which cells ae356
classified as HGR is set to 6000 gm-3h-1, and that below which cells are classified as LGR is set357
to 425 gm-3h-1.358
359
Model Simulation and Numerical Scheme360
The simulation represents a time march in which the occupancy states of each grid element is361
updated at discrete time steps of 1 h. Previous work analyzing the kinetics of the switching362
process from the vegetative state to the competent (EPS producing) state of Bacillus subtilis (B.363
subtilis) has shown that the duration of the switching period was 1.4 ± 0.3 h [57]. In addition,364
analysis of B. subtilis at the interface between the culture medium and air indicates that bacteria365
switch from the motile to the matrix-producing phenotype (downregulated to upregulated)366
between 10 min to 1h [58]. We use a multiscale integration approach with two distinct time367
scales: (i) cellular processes (biomass growth (Eq. 3), EPS production (Eq. 9), switching between368
up- and down-regulated states (Eq. 6), death by antibiotic (Eq. 13), cell division, and369
detachment) are monitored every 1 h, and (ii) within this “outer” time loop, concentrations of370
dissolved entities (nutrient (Eq. 2), autoinducer (Eq. 8), and antibiotic (Eq. 12)) are tracked by371
solving the diffusion-convection equations at a finer time resolution of 1x10 h. Numerical372
solutions to the diffusion-convection equations are obtained using a second-order Forward-Time373
Central-Space scheme.  Periodic boundary conditions are applied in the horizontal directions,374
and the Dirichlet boundary condition is imposed in the vertical direction. The Java programming375
(12)
)
(13)
language is used since it provides a convenient object-oriented framework that is well-suited for376
the individual based model described here.377
378
The parameter values used in the model are summarized in Table I.379
380
381
Results382
383
Biofilm growth dynamics in response to antibiotic treatment384
385
386
387
388
Fig. 1. Growth dynamics of QS- and QS+ biofilms in the absence and presence of antibiotic389
treatment. The number of live cells as a function of time for , = 4 for the390
untreated QS- biofilm (green), and when subjected to a continuous 24h (64-88 h) treatment of391
sub-MBEC ( , = 33 , red), and MBEC ( , = 34 , blue); the QS+ biofilm392
is subjected to , = 34 (orange)  (a), comparisons of average nutrient concentration393
(b), spatial distribution of average nutrient concentration (c) and spatial distribution of fraction of394
dead cells (d) for the QS- biofilm subjected to sub-MBEC and the untreated biofilm. Data in395
panels (c) and (d) are reported at 88 h, the time point at which treatment stops. The arrows in396
panel (a) represent – initial (64 h) and end (84 h) time points of antibiotic treatment. Data397
represent mean ± standard error of mean (SEM) of four replicate simulations.398
399
We simulated the growth dynamics of a bacterial biofilm over a period of 200 h, in the presence400
and absence of QS. In select runs, the biofilm was subjected to a continuous antimicrobial401
treatment ( , ranging from 15 to 60 gm-3) for duration of 24 h, initiated after 64 h of402
growth (cell number ~10,000). Whereas subjecting the biofilm to , of 34 gm-3 resulted in403
complete removal after 21 ± 0.5 h of treatment (Fig. 1a), a slightly lower antibiotic404
concentration (33 gm-3) was insufficient to eradicate the biofilm. Interestingly, biofilms treated405
with sub-MBEC ( , of 33 gm-3) exhibited a prolonged lifetime compared to even the406
untreated biofilms, with the former sloughing off at 113 ± 0.5 h while the latter at 184 ± 2.7 h407
(Fig. 1a). This is in line with the experimental observation that sub-MBEC treatment enhances408
biofilm formation [59]. The average nutrient concentration within the sub-MBEC-treated409
biofilm increased monotonically with time, and was higher compared to the untreated one (Fig.410
1b). This is a consequence of the fact that antibiotic-induced cell death in the sub-MBEC-411
treated biofilm causes the live cell number – and hence, the overall nutrient consumption – to412
decrease. In contrast, bacterial biomass in the untreated biofilm increases with time, resulting in413
increased nutrient consumption and reduced average nutrient concentration compared to the sub-414
MBEC-treated biofilm. The spatial distribution of nutrient concentration (measured as a415
function of the distance from the substratum) shows that nutrient penetration to the lower layers416
in the untreated biofilm was lower compared to the treated biofilm (Fig. 1c). This, in turn,417
causes cell death to occur near the bottom for the untreated biofilm, subsequently leading to418
sloughing (Fig. 1d). These findings are in agreement with experimental results showing that419
localized nutrient starvation is an environmental cue for the sloughing of biofilms [60]. In420
contrast, cell death was restricted to the top layers in the sub-MBEC-treated biofilm (Fig.421
1d). In agreement with experimental observations, sub-MBEC-treatment does not fully422
eradicate bacteria during the treatment phase [61], and biofilm thickness was restored to pre-423
treatment levels within 24 h after exposure to the antibiotic.424
425
MBEC for the QS+ biofilm was 51 gm-3, and was significantly higher than that for QS-.426
Comparing responses of the QS- and QS+ biofilms when subjected to a bulk antibiotic427
concentration of 34 gm-3 showed that whereas there was no significant difference in the viable428
cell counts for the first 8 hours of treatment, the live cell number for the QS+ biofilm reduced at429
a lower rate for the rest of the treatment (Fig. 1a).430
431
432
Comparison of responses to MBEC- and sub-MBEC-treatments433
434
435
436
Fig. 2. Response of the biofilm to MBEC and sub-MBEC treatments. The average antibiotic437
concentration (a) and fraction of dead cells (b) as a function of time, upon treatment with MBEC438
(blue) and sub-MBEC (red). Spatial profiles for antibiotic concentration (c), and fraction of439
dead cells (d) after 16 h of treatment for the MBEC-treated (blue) and sub-MBEC-treated (red)440
biofilms. Data represent mean ± standard error of mean (SEM) of four replicate simulations.441
442
To investigate the dramatically different responses of the QS- biofilms subjected to two slightly443
different antibiotic concentrations (MBEC and sub-MBEC), we tracked the temporal variation444
in the average antibiotic concentrations within the biofilms. A small difference in the bulk445
antibiotic concentrations (1 gm-3) was amplified to a much larger difference in average antibiotic446
concentrations within the biofilms; this difference was more pronounced at higher time points447
(after ~12 h of treatment) (Fig. 2a). This, in turn, led to higher cell death events in MBEC-448
treated biofilms compared to the ones treated with sub-MBEC (Fig. 2b). Under these conditions449
(after ~12 h of treatment), antibiotic penetration to the lower layers was more effective in the450
biofilm treated with MBEC compared to the one treated with sub-MBEC (Fig. 2c). For451
instance, after 16 h of treatment, the average antibiotic concentration at the substratum of the452
biofilm exposed to MBEC was ~7.5 times that of the biofilm treated with sub-MBEC (Fig.453
2c). This marked difference in local antibiotic concentrations in the lower regions of the biofilm454
resulted in significantly higher death events for the MBEC-treated biofilm compared to the455
biofilm treated with sub-MBEC (Fig. 2d). Whereas ~30% of the cells in the lowest layer died456
when the biofilm was subjected to MBEC, negligible cell death (~2%) occurred near the457
substratum of the sub-MBEC-treated biofilm (Fig. 2d). This difference in the fraction of dead458
cells at the bottom layers of the biofilm was observed at all treatment time points, ultimately459
leading to the eradication of the MBEC-treated biofilm. Similar trends were observed for the460
QS+ biofilm upon MBEC- (51 gm-3) and sub-MBEC (50 gm-3) treatments (data not shown).461
462
Correlation between cellular metabolism rates and antibiotic-induced death463
Biofilms comprise of bacterial cells in a wide range of physiological states, resulting in a464
spatially heterogeneous system. To investigate the influence of this spatial heterogeneity on the465
response of the biofilm to MBEC- and sub-MBEC treatments, we categorized live cells into466
three groups based on their growth rates: (i) metabolically active cells, exhibiting high growth467
rates (HGR), (ii) intermediate, and (iii) dormant cells, exhibiting low growth rates468
(LGR). There was a strong correlation between dead cells and HGR-cells in the presence of469
antibiotic treatment. On an average, during treatment, 59.79 ± 6.1% of HGR died at any given470
time step. On the other hand, LGR-cells were less susceptible to killing by antibiotic (~471
0.001%). In stark contrast, in the absence of antibiotic treatment, there was a strong correlation472
between dead cells and LGR-cells, with 34.15 ± 2.8% of LGR dying on an average at any given473
time step. Under these conditions, cell death occurred predominantly due to nutrient starvation474
at later time points (80 h onwards). The number of dead HGR-cells was negligible in the475
untreated biofilm.476
477
478
Spatial distribution of heterogeneous subpopulations in biofilms during treatment479
480
481
482
Fig. 3. Growth dynamics of subpopulations in the presence of antibiotic. Comparison of483
fraction of dormant cells (a), fraction of metabolically active cells (b) as a function of time for484 , = 4 gm-3. QS- biofilms treated with MBEC (blue) and sub-MBEC (red), and QS+485
biofilm subjected to , of 34 gm-3 (green). Data represent mean ± standard error of mean486
(SEM) of four replicate simulations.487
488
We tracked the dynamics of the distinct growth-rate-based cell subpopulations in QS- and QS+489
biofilms in response to antibiotic treatment.  Based on the fraction of HGR- and LGR-cells,490
three distinct phases were observed during 24 h of continuous antibiotic treatment (Figs. 3a and491
3b).  In the first phase that lasted ~4h, the total biomass reduced dramatically (~40% reduction).492
In this phase, the fraction of dormant cells increased with time, reaching a peak after 4h of493
treatment (Fig. 3a).  On the other hand, the subpopulation of active cells decreased with time494
(Fig. 3b).    After 4 h, the antibiotic consumption rates by dormant cells in the MBEC-treated495
biofilms were ~17 times higher compared to those of active cells (50.5 ± 9.4 gm-3 h-1 for496
dormant cells, versus 850.5 ± 65.4 gm-3 h-1 for active cells).  This indicates that metabolically497
active cells at the distal edge of the biofilm act as a reaction-diffusion barrier, thereby reducing498
antibiotic penetration to the LGR-cells near the substratum.  This results in lower antibiotic499
uptake rates by the LGR-cells, allowing them to survive antibiotic treatment.  The second phase500
lasted for ~8h, and was characterized by a decrease in the number of dormant cells (Fig. 3a).501
For the biofilm treated with MBEC, phases I and II were qualitatively similar to those observed502
for sub-MBEC treated biofilm. However phase II is delayed and prolonged in the biofilms503
treated with sub-MBEC (~5 h to 18 h) in comparison with MBEC-treated biofilms (4h to 12 h).504
The third phase was characterized by the complete eradication of the MBEC-treated biofilm.  In505
contrast, the sub-MBEC-treated biofilm survived in phase III.  More importantly, the fraction of506
active cells in the third phase of sub-MBEC treatment increased, resulting in the regrowth of the507
biofilm after the termination of antibiotic treatment.508
509
The QS+ biofilm survived treatment at , of 34 gm-3. In contrast to the QS- biofilm, the510
fraction of dormant cells increased monotonically in the third phase of QS+ biofilms (Fig. 3a).511
This could be a direct consequence of the increased viable cell number during treatment (Fig.512
1a), resulting in reduced nutrient availability in the lower regions of the biofilm. This starvation513
may lead to lower metabolic activity. Although both QS- and QS+ biofilm survived treatment514
with 33 gm-3, the mechanisms of survival appear to be different.  Whereas the QS- biofilm515
survives by rapidly transforming the metabolically inactive cells into active ones, the survival of516
the QS+ biofilm is a consequence of reduced exposure of the dormant cells to antibiotic.517
518
519
520
Spatial distribution of growth rates521
522
523
524
Fig. 4. Spatial heterogeneity in treated QS- and QS+ biofilm. Comparison of sub-MBEC525
(panels a, d, g, j, and m) and MBEC-treated QS- biofilms (panels b, e, h, k, n) and MBEC-526
treated QS+ biofilms (panels c, f, i, l, o) at different time points during 24 h treatment period.527
The spatial distribution of the fraction of dormant cells (panels a-c), active cells (panels d-f), and528
dead cells (panels g-i), local nutrient (panels j-l), and antibiotic concentrations (m-o). Data529
represent mean ± standard error of mean (SEM) of four replicate simulations.530
531
To investigate the biophysical mechanisms for the formation of surviving cell pockets within the532
antibiotic-treated biofilm, we tracked the growth rates of individual cells, the distribution of533
dead cells, and local nutrient and antibiotic concentrations as a function of their position within534
the biofilm. Prior to exposure to antibiotics (64 h of growth), a majority of the metabolically535
active cells are located at the upper layers (Figs. 4a-c), and dormant cells are localized at the536
lower layers (Figs. 4d-f). Upon initiation of treatment, cells at the biofilm-bulk liquid interphase537
are exposed to the antibiotic, resulting in cell death; cell death in the lower regions during this538
time period is negligible (Figs. 4g-i).  Because of the consumption of antibiotic by active cells in539
the top layers, antibiotic penetration to lower layers is reduced (Figs. 4m-o).  Cells in the lower540
layers are, thus, able to survive the initial period of treatment.  Consequently, the fraction of541
dormant cells increases near the substratum and active cells decreased at the top (Figs. 4d-f). At542
the end of phase I (4-6 h of treatment), nutrient penetration increased to the interior of the543
biofilm (Figs. 4j, 4k).  Subsequently, dormant cells located in the lower layers of the biofilm had544
improved nutrient accessibility, resulting in increased growth rates.  This, in turn, results in the545
transformation of inactive cells to the metabolically active state. This is validated by the546
observation that the fraction of dormant cells decreases and the fraction of active cells increases547
near the substratum over time (Figs. 4a, 4b, 4d, 4e).548
549
Antibiotic penetration to the lower layers in the MBEC-treated biofilm was higher compared to550
that in the sub-MBEC-treated biofilm (Fig. 4m, 4n). In the surviving QS+ biofilm (exposed to551 , of 34 gm-3), even the topmost bacterial cell was exposed to a local antibiotic552
concentration that was always less than 30% of the bulk value (Fig. 4o).  This is a direct553
consequence of the sequestration of the antibiotic by the cell-devoid layer of EPS that forms at554
the distal edge of the biofilm (Fig. 5a). In stark contrast, in the QS- biofilm subjected to555
treatment with MBEC, the local antibiotic concentration even at the substratum increased with556
time, reaching a maximum value of 22.5% of the bulk antibiotic concentration (after 20 h of557
treatment). Under these conditions, the local antibiotic concentration to which the topmost cell558
in the biofilm was exposed was as high as 50%.559
560
561
Influence of QS-regulated EPS production on antibiotic resistance in biofilms562
563
564
565
Fig. 5. Comparison of the response of QS+ and QS- biofilms to antibiotic treatment.566
Thickness of the cell-devoid layer of EPS at the top of the biofilm plotted as a function of567
treatment time (a), the difference between the average antibiotic concentrations at the biofilm568
surface and the substratum for QS+ (blue) and QS- (red) biofilms subjected to , of 34 gm-569
3 (b), the average killing depth for QS+ (blue) and QS- biofilms subjected to , of 34 gm-3570
(red) and , of 33 gm-3 (green) (c), and the total EPS produced for QS+ biofilms subjected571
to , of 50 gm-3 (red) and , of 51 gm-3 (blue) (d). Data represent mean ± standard572
error of mean (SEM) of four replicate simulations.573
574
Next, we compared the responses of the QS- (MBEC = 33 gm-3) and QS+ (MBEC = 51 gm-3)575
biofilms subjected to , of 34 gm-3. A cell-devoid layer of EPS is formed at the top of the576
QS+ biofilm, and the thickness of this layer increases as treatment proceeds (Fig. 5a). The577
extent of antibiotic penetration was quantified as the difference between the average antibiotic578
concentration at the surface of the biofilm and that at the substratum; lower the difference,579
higher the extent of penetration. Antibiotic penetration in the QS+ biofilm was significantly580
lower compared to that in the QS- biofilm (Fig. 5b), indicating that EPS sequesters antibiotic,581
thereby lowering the local concentrations in the interior of the biofilm. The largest distance582
from the surface of the biofilm at which antibiotic-induced cell death occurs was termed the583
killing depth. In agreement with the observation of fig. 5b, the killing depth for the QS- biofilms584
was higher than that for the QS+ biofilm.  The killing depth decreased monotonically with time585
for both QS- and QS+ biofilms as the biofilm thickness reduced. Interestingly, the QS+ biofilm586
subjected to a sub-MBEC treatment ( , of 51 gm-3) exhibited enhanced EPS production587
compared to that when subjected to the MBEC treatment (Fig. 5d).588
589
590
591
592
Fig. 6. QS- Biofilms treated with sub-MBEC (a, b, c, d, e) and MBEC (f, g, h, i, j), and QS+593
biofilms treated with MBEC (k, l, m, n, o). Visualization of 2D cross-sections showing high594
growth rate (green), intermediate growth rate cells (cyan), low-growth rate (blue), and locations595
of cell death (red), of the CN,bulk = 4 gm-3 biofilm after 0 h, 1 h, 4 h, 20 h, and 24 h of antibiotic596
introduction.  The yellow color represents EPS in QS+ biofilm.  The isolines show the antibiotic597
concentration distribution.598
599
Fig. 6 shows representative biofilm cross-sections at various stages of the response, illustrating600
the formation of surviving cell pockets within antibiotic-treated QS- and QS+ biofilms. After the601
first hour of treatment (panels 6a, 6e, and 6i), dormant cells (pink) were localized in the interior602
of the biofilm, and were surrounded by layers of cells exhibiting high (green), and intermediate603
(blue) growth rates. Antibiotic-induced cell death events (red) occurred at and near the biofilm-604
bulk liquid interface. For the QS- biofilms, thickness reduces as treatment continues, resulting605
in increased nutrient availability in the bottom layers.  This causes the slow-growing (pink) cells606
to transform into cells with intermediate- (blue) and high- (green) growth rates.  This is evident607
by the diminishing population of slow-growing cells in panels (6b), (6c), (6g), and (6h). For the608
QS+ biofilm, antibiotic-induced cell death events at the top resulted in the formation of a thin609
cell-devoid layer of EPS (yellow). This result is in agreement with experimental investigations610
that indicate that EPS was most abundant at the upper layers of the biofilm [62].  Antibiotic611
penetration was hindered by an interaction with the matrix of EPS, and results in the protection612
of bacterial cells in the lower layers.  These results are in agreement with previous experimental613
investigation that suggests that the production of EPS by QS, and the subsequent accumulation614
in the upper regions of the biofilm, plays a key role in biofilm resistance [41].615
616
Conclusions617
Although bacteria are traditionally investigated as planktonic entities, they predominantly occur618
as sessile, substratum-associated biofilms.  Bacteria associated with the biofilm mode of growth619
are more resistant to antibiotics, compared to their planktonic counterparts.  Several hypotheses620
have been proposed to explain this resistance including upregulation of virulence factors,621
formation of persister cells, genetic manipulations, slow penetration of the antibiotic, and the622
presence of dormant, slow-growing cells. Most of these mechanisms involve antibiotic623
resistance at the single-cell level, and do not account for the effects of intercellular population624
dynamics. Physical mechanisms of resistance like retarded penetration of the antibiotic may be625
a factor in the early stages of treatment, but as treatment proceeds and cells at the top die,626
antibiotic penetration to the lower layers increases.  Hence, retarded penetration of the antibiotic627
may not be a sufficient explanation as a protecting mechanism in biofilms.628
629
Biofilms comprise of physiologically distinct subpopulations of cells exhibiting varying growth630
rates, due in part to their adaptation to local environmental conditions. We have previously631
characterized this spatial heterogeneity in biofilms [43].  Interestingly, response of biofilms to632
an antibiotic challenge is also heterogeneous, with only certain subpopulations becoming633
resistant while the rest of the biofilm remains sensitive. Our goal was to investigate the634
influence of the biophysical features of the biofilm mode of growth on antibiotic resistance,635
when each individual cell itself is not necessarily tolerant to antibiotics. This may help delineate636
the effect of population dynamics on the antibiotic resistance in biofilms. We also wished to637
correlate the inherent spatial heterogeneity of biofilms at the cellular level to their heterogeneous638
response to treatment. Consequently, in our model, each bacterium was modeled as an639
independent entity, allowing us to monitor structural and chemical heterogeneities in the biofilm640
and in its response to treatment as a function of time and space.641
642
We first estimated the minimum antibiotic concentration required to eradicate biofilms in our643
simulations.  This allowed us to identify the largest antibiotic concentration that the biofilm is644
able to survive.  These are the conditions we used to further investigate mechanisms of645
antibiotic resistance in biofilms. Small differences in the bulk antibiotic concentrations were646
amplified into much larger differences in local antibiotic concentrations to which cells are647
exposed.  When subjected to MBEC and sub-MBEC treatments, the local antibiotic648
concentration near the substratum for the MBEC-treated biofilm was ~13 times higher compared649
to that for the sub-MBEC-treated biofilm, although the difference in the bulk antibiotic650
concentrations was small (1 gm-3). QS- (non-EPS producing) biofilms, subjected to an antibiotic651
challenge, responded by increasing the rate of transformation of dormant cells into faster652
growing, metabolically active cells. In contrast, QS+ biofilms responded by enhancing the rate653
of EPS production. Overall, insights into these biophysical mechanisms associated with the654
biofilm mode of growth may pave the way for novel therapeutic strategies to combat the655
antibiotic resistance of biofilms.656
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Table I.  Model parameters822
Parameter Description Value Unit Reference∆ Element length 3
Thickness of the DBL 18 [43]
( = , ) Number of elements in the direction 40
Initial number of bacterial cells 6
Maintenance coefficient 0.036 ℎ [43]
Maximum specific growth rate of bacterial
population
0.3125 ℎ [43]
Yield coefficient for biomass 0.45 [43]
Time in the stationary phase at which cell
death occurs
24 ℎ [43]
Ratio of the rate of nutrient consumption to
that of endogenous metabolism below
which cell death occurs
0.15 [43]
Threshold biomass at which cell division
occurs
2 x 10-12
Diffusion coefficient of nutrient 0.84 x 10-6 ℎ [43]
Monod saturation constant 2.55 [43], Bulk nutrient concentration 4
Yield coefficient for EPS 0.27 [43]
Threshold concentration at which EPS
division occurs
33000 [43]
Diffusion coefficient of autoinducer 1 x 10-6 ℎ, Autoinducer production rate by up-
regulated cells
73800 ℎ [52]
, Autoinducer production rate by down-
regulated cells
498 ℎ [52]
Spontaneous up-regulation rate 7.89 x 10-
17
ℎ [52, 63]
Spontaneous down-regulation rate 0.975 ℎ [52, 63]
Transition constant 7.96 x 10-
17
[52, 63]
Diffusion coefficient of antibiotic 0.36 x 10-6 ℎ [54]
Antibiotic half-saturation coefficient 1 [54]
Maximum specific reaction rate of
antibiotic with bacterial cell
2.5 ℎ [54]
BIC Biofilm inhibitory concentration 1- 64 [64]
Maximum specific reaction rate of
antibiotic with EPS
0.25 ℎ
823
